Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …

Objectives To determine if and to what degree asthma may predispose to worse COVID-19
outcomes in order to inform treatment and prevention decisions, including shielding and …

Background Chronic respiratory diseases (CRD) are common among patients with
coronavirus disease 2019 (COVID-19). Objectives We sought to determine the association …

Background During follow-up, patients severely affected by coronavirus disease 2019
(COVID-19) requiring invasive mechanical ventilation (IMV), show symptoms of Post …

Therapeutic Advances in Respiratory Disease 15 2 journals. sagepub. com/home/tar in the
COVID-19 cohort relative to the matched cohort. Of the 8070 patients with COVID-19, 132 …

Introduction The prevalence of asthma in patients hospitalized with SARS-CoV-2 has been
studied and varies widely in the different series. However, the prevalence in SARS-infected …

Outcomes for patients with COVID-19 infection have been widely reported for the initial peak
of the pandemic. 1 However, there is a lack of data describing outcomes and characteristics …

Objective: Higher probability of developing severe COVID-19 has been associated with
health risk factors and medical conditions which are common among workers globally. For at …

Since December 2019, the ongoing pandemic of coronavirus disease 2019 (COVID-19),
with the culprit pathogen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Bronchiectasis (BE) has been linked to past viral infections such as influenza, measles, or
adenovirus. Two years ago, a new pandemic viral infection severe acute respiratory …